JP2006335694A5 - - Google Patents

Download PDF

Info

Publication number
JP2006335694A5
JP2006335694A5 JP2005163086A JP2005163086A JP2006335694A5 JP 2006335694 A5 JP2006335694 A5 JP 2006335694A5 JP 2005163086 A JP2005163086 A JP 2005163086A JP 2005163086 A JP2005163086 A JP 2005163086A JP 2006335694 A5 JP2006335694 A5 JP 2006335694A5
Authority
JP
Japan
Prior art keywords
osteoarthritis
molecular weight
low molecular
therapeutic agent
weight hyaluronan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005163086A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006335694A (ja
JP4041856B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2005163086A priority Critical patent/JP4041856B2/ja
Priority claimed from JP2005163086A external-priority patent/JP4041856B2/ja
Publication of JP2006335694A publication Critical patent/JP2006335694A/ja
Publication of JP2006335694A5 publication Critical patent/JP2006335694A5/ja
Application granted granted Critical
Publication of JP4041856B2 publication Critical patent/JP4041856B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2005163086A 2005-06-02 2005-06-02 変形性関節症の治療剤 Expired - Lifetime JP4041856B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005163086A JP4041856B2 (ja) 2005-06-02 2005-06-02 変形性関節症の治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005163086A JP4041856B2 (ja) 2005-06-02 2005-06-02 変形性関節症の治療剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007192197A Division JP2007262103A (ja) 2007-07-24 2007-07-24 変形性関節症の治療剤

Publications (3)

Publication Number Publication Date
JP2006335694A JP2006335694A (ja) 2006-12-14
JP2006335694A5 true JP2006335694A5 (enExample) 2007-09-06
JP4041856B2 JP4041856B2 (ja) 2008-02-06

Family

ID=37556549

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005163086A Expired - Lifetime JP4041856B2 (ja) 2005-06-02 2005-06-02 変形性関節症の治療剤

Country Status (1)

Country Link
JP (1) JP4041856B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1994934A4 (en) * 2006-12-05 2010-03-10 Glycoscience Lab Inc THERAPEUTIC AGENT AGAINST DEGENERATIVE ARTHRITIS
WO2013125634A1 (ja) * 2012-02-22 2013-08-29 株式会社ヒアルロン酸研究所 ヒアルロン酸フラグメントを有効成分とするサーチュイン誘導剤、組織修復剤、肝細胞増殖因子誘導剤、組織恒常性維持剤、及びｔｌｒ４作用剤

Similar Documents

Publication Publication Date Title
JP2010522242A5 (enExample)
CY1119839T1 (el) Στερεες μορφες δοσεως μπενταμουστινης
EP2444072A3 (en) Non-mucoadhesive film dosage forms
JP2006502129A (ja) 腎臓濾過および腎臓通過中のリソソーム分解に対して耐性を示す抗微生物性荷電ポリマー、その組成物および使用方法
CL2007001132A1 (es) Compuestos derivados de purina sustituida con otros sistemas heterociclicos; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria u obstructiva de las vias respiratorias.
JP2009532087A5 (enExample)
NO20084919L (no) Oksadiazolidindionforbindelse
EP4538227A3 (en) Sodium thiosulfate-containing pharmaceutical compositions
NO20083562L (no) Cannabinoidreseptormodulatorer
WO2008042688A3 (en) Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
JP2003522796A5 (enExample)
JP2009542581A5 (enExample)
WO2008149802A1 (ja) アンドログラホリドを有効成分とする抗疲労剤及び経口組成物
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
WO2008090631A1 (ja) フコイダン由来オリゴ糖
JP2009537554A5 (enExample)
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害（ａｄｈｄ）の治療方法
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
WO2004098564A3 (en) Biodegradable nanoparticles comprising an aminoglycoside and a polymer like a polysaccharide
JP2005507891A5 (enExample)
NO20070146L (no) 4-fenylpyrimidin-2-karbonitril-derivater
EP2455085A3 (en) Use of at least one compound of the family of the avermectins or of the family of the milbemycins in the treatment of ophthalmic pathologies
JP2022532038A5 (enExample)
WO2009041111A1 (ja) 経口投与剤
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist